English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community
Ruth de Jauregui | Jun 10, 2017

Amgen says Xgeva trial shows promise as option for patients with multiple myeloma

Ruth de Jauregui | Jun 10, 2017

American Cancer Society points out health care barriers the LGBT community faces

Ruth de Jauregui | Jun 8, 2017

BioMarin's Brineura gets European approval for treating CLN2 brain disease in children

Ruth de Jauregui | Jun 8, 2017

Anthem leaving Ohio health insurance exchange

Ruth de Jauregui | Jun 8, 2017

American Heart Association reports arteries can stay healthy into 70s and beyond

Michael McGrady | Jun 8, 2017

American Medical Association applauds Anthem-Cigna merger rejection

Michael McGrady | Jun 7, 2017

Federal agencies weigh in on Zika outbreak response

Ruth de Jauregui | Jun 7, 2017

Amgen reports positive results using Imlygic, Yervoy to treat melanoma

Trending

Patient Daily | Jul 8, 2025

Clinical assistant professor at Stanford: ‘Musical background is associated with better performance of fundamental surgical skills'

+ Pharmaceuticals
Patient Daily | Jul 10, 2025

PhRMA Executive VP: ‘State policymakers can lead the way and must address 340B abuse and protect patients from PBMs'

Patient Daily | Jul 9, 2025

FDA approves Longeveron's Phase 2 study for pediatric dilated cardiomyopathy treatment

+ Pharmaceuticals
Patient Daily | Jul 8, 2025

Psychedelic mushrooms' compound shows potential antiaging effects

  • « First
  • «
  • …
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2025 Patient Daily